Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Intermediate I. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN108191778A reveals one pot synthesis reducing costs. Enhances supply chain reliability for high purity pharmaceutical intermediates manufacturing globally.
Patent CN112795606A reveals a novel PNP/NRK enzymatic route for NMN. Achieve superior conversion rates and cost efficiency in pharmaceutical intermediate manufacturing.
Novel synthesis of 4'-hydroxy-4,6'-dimethoxydihydrochalcone via Pd/C hydrogenation offers high purity and scalable pharmaceutical intermediate production.
Advanced purification method for Glimepiride achieving >99.9% purity. Optimized solvent systems reduce impurities and ensure scalable manufacturing for diabetes medication supply chains.
Novel copper-catalyzed route offers high yield and green chemistry advantages for pharmaceutical and OLED material supply chains globally.
Patent CN101260092B details a cost-effective, water-based synthesis for Cinepazide Maleate, offering high purity and stable crystal forms for cardiovascular drug manufacturing.
Patent CN108191625B details a high-yield (>78%) room temperature synthesis of Shogaol intermediates, offering significant cost reduction in pharmaceutical intermediate manufacturing compared to cryogenic methods.
Patent CN103044345B offers a two-step synthesis for Flomoxef intermediate with high yield and purity, reducing cost and waste for reliable supply chains.
Patent CN110004119B discloses a thermostable epsilon-ketoester reductase mutant enabling efficient synthesis of (R)-alpha-lipoic acid precursors with reduced catalyst loading and enhanced stability.
Novel synthetic route for Zofenopril Calcium offering high purity and scalable production for global pharmaceutical supply chains and cost reduction.
Patent CN104327073B details a safer semi-synthetic route for Vinpocetine, eliminating column chromatography to ensure high purity and cost reduction in API manufacturing.
Patent CN113149911A details a green hydrogenation route for 5-aminobenzimidazole ketone. Achieve high purity and yield with reduced environmental impact for scalable supply.
Patent CN108823179A reveals high-efficiency transaminase mutant for R-3-aminobutanol, offering significant cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN109438474A details a novel synthetic route for Pestaloxazine A intermediates, offering high purity and scalable manufacturing for antiviral drug development.
Novel nickel catalyst method for benzimidazole quinazoline synthesis offers cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN104311625B reveals a cost-effective synthesis route for fluocinolone acetate intermediates, offering significant supply chain stability and purity advantages for pharmaceutical manufacturers.
Patent CN101555218A reveals a novel NaOH/PEG-1000 method. Offers high yield and cost reduction for electronic chemical manufacturing and pharma intermediates.
Novel Penicillium-derived monoamine oxidase enables high-concentration biocatalysis for antiviral drug intermediates, ensuring supply chain stability and cost efficiency.
Novel C-shaped supramolecular carrier synthesis via acid-catalyzed condensation. High purity, scalable process for drug delivery and catalysis applications.
Patent CN112359036B discloses engineered nitrilase mutants for efficient synthesis of pregabalin chiral intermediates, offering significant cost reduction in API manufacturing.